What we’re about
Who Are We:
EPPIC Global is a Broad Based and Cross Disciplinary Networking Group for HealthCare. Our community includes, but not limited to, biologists, physicians, chemists, bioengineers, software engineers, data scientists, clinical pharmacologists, statisticians and project managers. We share a common vision of bringing innovative products (medicines, diagnostics, healthcare technology) to patients and their caregivers, through the integration of diverse disciplines and entrepreneurship.
Why Do We Exist:
Delivery of timely, high quality and affordable healthcare to patients remains an unmet need. The 21st century healthcare ecosystem is witnessing the unprecedented convergence of technology and life sciences, a rising new generation of inspirational entrepreneurs and a greater risk-taking sentiment among investors. These changes are fueling radical new approaches to discovery and development of medicines, disruption of traditional R&D, devices and diagnostics and there is no better example of this than the remarkable speed at which the healthcare industry delivered transformative treatments and diagnostics during the COVID pandemic.
Every life science and technology vertical and sub-segment has associations and networking platforms for its members but few platforms exist for all of them to come together to address the needs of the changing configuration of the healthcare professional workplace. Through our history and because of our clear focus on a geographical cluster in the Bay Area, EPPIC Global evolved into a broad platform for healthcare professionals of all genres- under the common umbrella theme – Technology meets Healthcare.
What is Our Mission:
To serve as a premium forum for networking, mentorship, information sharing and entrepreneurial support of like-minded healthcare professionals with diverse backgrounds and experiences. We achieve our mission through networking events, mentorship, webinars, and our annual EPPICon conference
Join us for an engaging EPPIC meetup focused on actionable strategies to navigate the evolving landscape of biologics manufacturing. From leveraging AI in bioprocessing to building resilient global supply chains, this event will highlight real-world case studies, expert perspectives, and technology spotlights designed to accelerate innovation while managing risk.
This event is jointly hosted by our sponsors for the event Kemwell Biopharma & Bioprocess.ai
**Time:**4:30 PM – 7:00 PM
Agenda Highlights:
Opening Keynote (45 min):
Kemwell Biopharma – A One-Stop Solution to Accelerate Your Biologics Pipeline
Includes a case study of a U.S. biotech gaining timeline advantage through integrated, end-to-end manufacturing at a single site.
Technology Spotlight (30 min):
Bioprocess AI – Leveraging AI in Bioprocessing to Drive Speed, Quality, and Scalability
Case Study Presentation (30 min):
Preliminary Evaluation of Combining AI and CDMO Capabilities to Reduce Cycle Time and Enhance Data Management
Panel Discussion (40 min):
Building a Resilient Biologics Supply Chain Beyond China – Evaluating Western CDMOs vs. Emerging Hubs like India and APAC
Moderator: TBD
Panelists:
- Mr. Rangan (VP, Protein Science and Early CMC, CytomX)
- Mr. Mohan Srinivasan (Associate VP, Biologics Oncology)
- Ms. Amita Goel (Founder, Celtheon)
Who Should Attend:
Biotech and pharma professionals, CDMO leaders, CMC and supply chain experts, AI innovators, and investors interested in the future of biologics manufacturing.
About our sponsors:
Kemwell Biopharma
Located in Bangalore, India, Kemwell Biopharma is an end-to-end biologics CDMO with fully integrated development and cGMP manufacturing services from process design through commercial drug product. Their platform supports mammalian cell culture for mAbs, bispecifics and fusion proteins, with >4,500 L reactor capacity and automated fill/finish operations, all operating at the site of development. Trusted by global pharma since 1980 and accredited by stringent international audits, Kemwell enables scalable biologics delivery with agility and regulatory compliance.
Bioprocess.AI
Founded in 2023, Bioprocess.AI delivers a SaaS platform tailored for bioprocess scientists, acting as an AI “co‑pilot” through development, scale‑up, and manufacturing. With tools like SmartELN for automated documentation, run‑to‑run analytics, predictive monitoring, and one‑click CMC insights, Bioprocess.AI accelerates translation from bench to clinic while reducing manual bottlenecks.
Upcoming events (1)
See all- Biologics manufacturing in uncertain timesThe Hangar, South San Francisco, CA
Join us for an engaging EPPIC meetup focused on actionable strategies to navigate the evolving landscape of biologics manufacturing. From leveraging AI in bioprocessing to building resilient global supply chains, this event will highlight real-world case studies, expert perspectives, and technology spotlights designed to accelerate innovation while managing risk.
This event is jointly hosted by our sponsors for the event Kemwell Biopharma & Bioprocess.ai
**Time:**4:30 PM – 7:00 PM
Agenda Highlights:
Opening Keynote (45 min):
Kemwell Biopharma – A One-Stop Solution to Accelerate Your Biologics Pipeline
Includes a case study of a U.S. biotech gaining timeline advantage through integrated, end-to-end manufacturing at a single site.Technology Spotlight (30 min):
Bioprocess AI – Leveraging AI in Bioprocessing to Drive Speed, Quality, and ScalabilityCase Study Presentation (30 min):
Preliminary Evaluation of Combining AI and CDMO Capabilities to Reduce Cycle Time and Enhance Data ManagementPanel Discussion (40 min):
Building a Resilient Biologics Supply Chain Beyond China – Evaluating Western CDMOs vs. Emerging Hubs like India and APACModerator: TBD
Panelists:
- Mr. Rangan (VP, Protein Science and Early CMC, CytomX)
- Mr. Mohan Srinivasan (Associate VP, Biologics Oncology)
- Ms. Amita Goel (Founder, Celtheon)
Who Should Attend:
Biotech and pharma professionals, CDMO leaders, CMC and supply chain experts, AI innovators, and investors interested in the future of biologics manufacturing.About our sponsors:
Kemwell Biopharma
Located in Bangalore, India, Kemwell Biopharma is an end-to-end biologics CDMO with fully integrated development and cGMP manufacturing services from process design through commercial drug product. Their platform supports mammalian cell culture for mAbs, bispecifics and fusion proteins, with >4,500 L reactor capacity and automated fill/finish operations, all operating at the site of development. Trusted by global pharma since 1980 and accredited by stringent international audits, Kemwell enables scalable biologics delivery with agility and regulatory compliance.Bioprocess.AI
Founded in 2023, Bioprocess.AI delivers a SaaS platform tailored for bioprocess scientists, acting as an AI “co‑pilot” through development, scale‑up, and manufacturing. With tools like SmartELN for automated documentation, run‑to‑run analytics, predictive monitoring, and one‑click CMC insights, Bioprocess.AI accelerates translation from bench to clinic while reducing manual bottlenecks.